in a randomized double-blinded fashion , herpes simplex virus type 2 specific lymphocyte proliferation ( hsv-2-lp ) was studied in patients with frequently recurring genital hsv-2 who were administered daily suppressive oral acyclovir ( s-acv ) or placebo and acyclovir for 5 d ( plc/acv ) with recurrences .
C0019342
genital hsv
C0001367
acyclovir